Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Nkarta, Inc. | Chief Medical Officer, Head of Research & Development | Common Stock | 139K | $708K | $5.11 | Aug 21, 2024 | Direct |
Nkarta, Inc. | Chief Medical Officer, Head of Research & Development | Stock Option (right to buy) | 30K | Jul 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NKTX | Nkarta, Inc. | Aug 21, 2024 | 1 | -$6.91K | 4 | Aug 23, 2024 | Chief Medical Officer, Head of Research & Development |
NKTX | Nkarta, Inc. | Jul 15, 2024 | 2 | $0 | 4 | Jul 31, 2024 | Chief Medical Officer, Head of Research & Development |
NKTX | Nkarta, Inc. | Jun 18, 2024 | 1 | -$2.55K | 4 | Jun 20, 2024 | Chief Medical Officer |
NKTX | Nkarta, Inc. | Jan 16, 2024 | 1 | -$31K | 4 | Jan 18, 2024 | Chief Medical Officer |
NKTX | Nkarta, Inc. | Jan 4, 2024 | 2 | $0 | 4 | Jan 8, 2024 | Chief Medical Officer |
NKTX | Nkarta, Inc. | Aug 21, 2023 | 1 | -$2.44K | 4 | Aug 23, 2023 | Chief Medical Officer |
NKTX | Nkarta, Inc. | Jul 1, 2023 | 1 | $0 | 4 | Jul 5, 2023 | Chief Medical Officer |
NKTX | Nkarta, Inc. | Jun 20, 2023 | 1 | -$2.13K | 4 | Jun 22, 2023 | Chief Medical Officer |
NKTX | Nkarta, Inc. | Jan 13, 2023 | 3 | -$961 | 4 | Jan 18, 2023 | Chief Medical Officer |
NKTX | Nkarta, Inc. | Jan 1, 2023 | 0 | $0 | 3 | Jan 10, 2023 | Chief Medical Officer |